Company Filing History:
Years Active: 2017-2022
Title: Nadia Raffaelli: Innovator in Pharmaceutical Research
Introduction
Nadia Raffaelli is a prominent inventor based in Ancona, Italy. She has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target specific metabolic pathways. With a total of 3 patents to her name, Raffaelli is recognized for her innovative approaches to treating various diseases.
Latest Patents
Raffaelli's latest patents focus on inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase (ACMSD). These compounds are designed to modulate the activity of ACMSD, which is crucial for the prevention and treatment of diseases associated with defects in NAD biosynthesis. Such diseases include metabolic disorders, neurodegenerative diseases, chronic inflammatory diseases, kidney diseases, and age-related conditions. The patents also disclose pharmaceutical compositions that incorporate these compounds, highlighting their potential use as medicaments.
Career Highlights
Nadia Raffaelli has established herself as a key figure in her field through her innovative research and development efforts. She is currently associated with Tes Pharma S.r.l., where she continues to advance her work in pharmaceutical sciences. Her contributions have been instrumental in the exploration of new therapeutic avenues.
Collaborations
Raffaelli collaborates with notable professionals in her field, including Roberto Pellicciari and Johan Auwerx. These partnerships enhance her research capabilities and foster innovation in the development of new treatments.
Conclusion
Nadia Raffaelli's work exemplifies the impact of innovative research in the pharmaceutical industry. Her patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.